New York S09279 mandates gene synthesis providers and equipment manufacturers to follow health department regulations, including identifying.
New York S09279, known as the "bioterrorism prevention act," amends the public health law by adding a new article, GENE SYNTHESIS LABS. It requires gene synthesis providers and manufacturers of gene synthesis equipment to operate according to rules and regulations issued by the department of health. These regulations include identifying potentially dangerous genetic sequences, screening potential customers, and retaining records of genes synthesized and/or delivered.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.